| NAME |
ABALOPARATIDE 80MCG/0.04ML INJ,PEN,1.56ML |
| VA GENERIC NAME |
ABALOPARATIDE |
| DOSAGE FORM |
INJ,SOLN |
| FDA MED GUIDE |
Abaloparatide_(Tymlos)_(2022).pdf |
| FORMULARY DESIGNATOR |
PA-F |
| ACTIVE INGREDIENTS |
|
| NATIONAL FORMULARY INDICATOR |
YES |
| CS FEDERAL SCHEDULE |
Unscheduled |
| STRENGTH |
80 |
| SINGLE/MULTI SOURCE PRODUCT |
Single source |
| UNITS |
MCG/0.04ML |
| NATIONAL FORMULARY NAME |
ABALOPARATIDE INJ,SOLN |
| CREATE DEFAULT POSSIBLE DOSAGE |
NO |
| POSSIBLE DOSAGES TO CREATE |
No Possible Dosages |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2017-07-01 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
ABALOPARATIDE 80MCG/0.04ML PEN 1.56ML |
| VA PRODUCT IDENTIFIER |
A1933 |
| TRANSMIT TO CMOP |
YES |
| VA DISPENSE UNIT |
EA |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4036669 |
| EFFECTIVE DATE/TIME |
-
- 2017-05-12 00:00:00
- STATUS: ACTIVE
|
